Evidence map›Paper›PMID 23613777›Full record

ArticlePloS one2013

Association of SNPs of CD40 gene with multiple sclerosis in Russians.

Ekaterina Alekseevna Sokolova, Nadezhda Alekseevna Malkova, Denis Sergeevich Korobko, Aleksey Sergeevich Rozhdestvenskii, Anastasia Vladimirovna Kakulya, Elena Vladimirovna Khanokh, Roman Andreevich Delov, Fedor Alekseevich Platonov, Tatyana Yegorovna Popova, Elena Gennadievna Aref' eva and 18 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 13 institutions in 1 country.

Ekaterina Alekseevna SokolovaPharmacogenomics Group, Institute of Chemical Biology and Fundamental Medicine, Siberian Division, Russian Academy of Sciences, Novosibirsk, Russia. sokolovaea2608@gmail.ru
Nadezhda Alekseevna Malkova
Denis Sergeevich Korobko
Aleksey Sergeevich Rozhdestvenskii
Anastasia Vladimirovna Kakulya
Elena Vladimirovna Khanokh
Roman Andreevich Delov
Fedor Alekseevich Platonov
Tatyana Yegorovna Popova
Elena Gennadievna Aref' eva
Natalia Nikolaevna Zagorskaya
Valentina Mikhailovna Alifirova
Marina Andreevna Titova
Inna Vadimovna Smagina
Svetlana Alksandrovna El' chaninova
Anna Valentinovna Popovtseva
Valery Pavlovich Puzyrev
Olga Georgievna Kulakova
Ekaterina Yur'evna Tsareva
Olga Olegovna Favorova
Sergei Gennadievich Shchur
Natalia Yurievna Lashch
Natalia Fyodorovna Popova
Ekaterina Valerievna Popova
Evgenii Ivanovich Gusev
Aleksey Nikolaevich Boyko
Yurii Sergeevich Aulchenko
Maxim Leonidovich Filipenko
Pirogov Russian National Research Medical University · RUAltai State Medical University · RUBudgetary Healthcare Institution of Omsk Region Regional Clinical Hospital · RUOmsk State Medical University · RUSiberian Branch of the Russian Academy of Sciences · RUFederal Agency for Health and Social Development · RUInstitute of Chemical Biology and Fundamental Medicine · RUKemerovo Cardiology Center · RUKemerovo State University · RUMinistry of Health of the Russian Federation · RUNorth-Eastern Federal University · RUResearch Institute of Medical Genetics of Russian Academy of Medical Sciences · RUSiberian State Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) is a serious, incurable neurological disease. In 2009, the ANZgene studies detected the suggestive association of located upstream of CD40 gene in chromosome 20q13 (p = 1.3×10(-7)). Identification of the causal variant(s) in the CD40 locus leads to a better understanding of the mechanism underlying the development of autoimmune pathologies. We determined the genotypes of rs6074022, rs1883832, rs1535045, and rs11086996 in patients with MS (n = 1684) and in the control group (n = 879). Two SNPs were significantly associated with MS: rs6074022 (additive model C allele OR = 1.27, 95% CI = [1.12-1.45], p = 3×10(-4)) and rs1883832 (additive model T allele OR = 1.20, 95% CI = [1.05-1.38], p = 7×10(-3)). In the meta-analysis of our results and the results of four previous studies, we obtain the association p-value of 2.34×10(-12), which confirmed the association between MS and rs6074022 at a genome-wide significant level. Next, we demonstrated that the model including rs6074022 only sufficiently described the association. From our analysis, we can speculate that the association between rs1883832 and MS was induced by LD, whereas rs6074022 was a marker in stronger LD with the functional variant or was the functional variant itself. Our results indicated that the functional variants were located in the upstream region of the gene CD40 and were in higher LD with rs6074022 than LD with rs1883832.

Indexed as

Polymorphism, Single NucleotideAdultAllelesCD40 AntigensFemaleHaplotypesHumansLogistic ModelsMaleMultiple SclerosisRussiaCD40 Antigens

Identifiers

PMID23613777
PMCPMC3632563
OpenAlexW2102736135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.